協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/06/21 | 2,691 | 2,721 | 2,685 | 2,693.5 | +3.5 | +0.1% | 1,153,400 |
2024/06/20 | 2,683 | 2,694.5 | 2,670.5 | 2,690 | +10.5 | +0.4% | 731,100 |
2024/06/19 | 2,650 | 2,679.5 | 2,629.5 | 2,679.5 | +29.5 | +1.1% | 1,431,500 |
2024/06/18 | 2,690.5 | 2,693.5 | 2,644 | 2,650 | -67.5 | -2.5% | 1,424,700 |
2024/06/17 | 2,763.5 | 2,769 | 2,693.5 | 2,717.5 | -30 | -1.1% | 1,072,700 |
2024/06/14 | 2,685 | 2,756.5 | 2,651 | 2,747.5 | +61.5 | +2.3% | 2,426,300 |
2024/06/13 | 2,693 | 2,697.5 | 2,655.5 | 2,686 | -7 | -0.3% | 702,800 |
2024/06/12 | 2,731 | 2,746 | 2,690 | 2,693 | -33.5 | -1.2% | 1,014,200 |
2024/06/11 | 2,727 | 2,737.5 | 2,715 | 2,726.5 | -1 | ±0% | 697,400 |
2024/06/10 | 2,704.5 | 2,743.5 | 2,703 | 2,727.5 | +23 | +0.9% | 817,300 |
2024/06/07 | 2,675 | 2,709 | 2,675 | 2,704.5 | +11.5 | +0.4% | 815,000 |
2024/06/06 | 2,730 | 2,732 | 2,681.5 | 2,693 | -11 | -0.4% | 1,026,300 |
2024/06/05 | 2,722 | 2,731.5 | 2,693 | 2,704 | -4 | -0.1% | 1,013,800 |
2024/06/04 | 2,666 | 2,722.5 | 2,658.5 | 2,708 | +27.5 | +1% | 905,600 |
2024/06/03 | 2,658.5 | 2,711 | 2,654 | 2,680.5 | +25 | +0.9% | 864,800 |
2024/05/31 | 2,600 | 2,655.5 | 2,597.5 | 2,655.5 | +74 | +2.9% | 4,286,700 |
2024/05/30 | 2,559 | 2,590 | 2,536 | 2,581.5 | +22.5 | +0.9% | 866,600 |
2024/05/29 | 2,557.5 | 2,576.5 | 2,550.5 | 2,559 | -16 | -0.6% | 1,053,900 |
2024/05/28 | 2,580 | 2,591.5 | 2,555.5 | 2,575 | -8 | -0.3% | 966,300 |
2024/05/27 | 2,562.5 | 2,586 | 2,540 | 2,583 | +15 | +0.6% | 829,500 |
2024/05/24 | 2,567.5 | 2,575.5 | 2,549.5 | 2,568 | -22 | -0.8% | 844,400 |
2024/05/23 | 2,550 | 2,595.5 | 2,546.5 | 2,590 | +24.5 | +1% | 1,018,900 |
2024/05/22 | 2,586 | 2,592.5 | 2,556 | 2,565.5 | -25.5 | -1% | 856,100 |
2024/05/21 | 2,611 | 2,622.5 | 2,591 | 2,591 | -27.5 | -1.1% | 711,900 |
2024/05/20 | 2,602 | 2,642.5 | 2,602 | 2,618.5 | +6 | +0.2% | 799,100 |
2024/05/17 | 2,621 | 2,641 | 2,593 | 2,612.5 | -41.5 | -1.6% | 987,300 |
2024/05/16 | 2,620 | 2,668.5 | 2,620 | 2,654 | +15 | +0.6% | 972,100 |
2024/05/15 | 2,668.5 | 2,690.5 | 2,627.5 | 2,639 | -55.5 | -2.1% | 1,136,000 |
2024/05/14 | 2,686.5 | 2,716 | 2,675 | 2,694.5 | +23 | +0.9% | 962,400 |
2024/05/13 | 2,653.5 | 2,689.5 | 2,650 | 2,671.5 | +2 | +0.1% | 762,800 |
2024/05/10 | 2,679 | 2,710 | 2,666 | 2,669.5 | +25 | +0.9% | 982,600 |
2024/05/09 | 2,638.5 | 2,698 | 2,634.5 | 2,644.5 | +10 | +0.4% | 1,175,400 |
2024/05/08 | 2,636 | 2,685 | 2,602 | 2,634.5 | -51.5 | -1.9% | 1,917,700 |
2024/05/07 | 2,667 | 2,703 | 2,653.5 | 2,686 | +18.5 | +0.7% | 1,693,300 |
2024/05/02 | 2,668.5 | 2,684 | 2,650.5 | 2,667.5 | ±0 | ±0% | 954,600 |
2024/05/01 | 2,637.5 | 2,701.5 | 2,633 | 2,667.5 | +18.5 | +0.7% | 1,044,900 |
2024/04/30 | 2,683 | 2,683 | 2,644 | 2,649 | +19 | +0.7% | 1,219,400 |
2024/04/26 | 2,618.5 | 2,650 | 2,603 | 2,630 | +6 | +0.2% | 857,100 |
2024/04/25 | 2,653 | 2,665 | 2,624 | 2,624 | -29 | -1.1% | 875,000 |
2024/04/24 | 2,638.5 | 2,682.5 | 2,622.5 | 2,653 | -2.5 | -0.1% | 910,300 |
2024/04/23 | 2,642.5 | 2,682.5 | 2,642.5 | 2,655.5 | -0.5 | ±0% | 1,118,900 |
2024/04/22 | 2,646 | 2,666 | 2,631.5 | 2,656 | +47 | +1.8% | 1,077,100 |
2024/04/19 | 2,635 | 2,639 | 2,584 | 2,609 | -26 | -1% | 1,129,100 |
2024/04/18 | 2,653.5 | 2,679 | 2,631 | 2,635 | +11.5 | +0.4% | 1,033,500 |
2024/04/17 | 2,655 | 2,672 | 2,623.5 | 2,623.5 | -33.5 | -1.3% | 937,200 |
2024/04/16 | 2,642 | 2,666 | 2,624.5 | 2,657 | -12.5 | -0.5% | 1,019,100 |
2024/04/15 | 2,659 | 2,677.5 | 2,644.5 | 2,669.5 | -12 | -0.4% | 940,800 |
2024/04/12 | 2,644.5 | 2,695.5 | 2,642 | 2,681.5 | +37 | +1.4% | 1,121,700 |
2024/04/11 | 2,590 | 2,647 | 2,588.5 | 2,644.5 | +37.5 | +1.4% | 968,900 |
2024/04/10 | 2,648.5 | 2,653.5 | 2,599 | 2,607 | -23.5 | -0.9% | 965,200 |
251~
300
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 243,700円 | -3.5% | -11.3% | 2.46% | 22.38倍 | 1.52倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.16倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,800円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 407,300円 | +0.1% | -3.4% | 3.93% | 27.69倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 153,900円 | +0.6% | +43.3% | 5.20% | 10.79倍 | 0.94倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム